{"nctId":"NCT04300231","briefTitle":"Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy","startDateStruct":{"date":"2019-10-22","type":"ACTUAL"},"conditions":["Cystectomy"],"count":160,"armGroups":[{"label":"Thoracic epidural","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: epidural bupivacaine 0.05%","Drug: /hydromorphone 0.05mg/ml"]},{"label":"Rectus Sheath Block","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Liposomal bupivacaine","Drug: bupivacaine 0.125%","Drug: injectable saline"]},{"label":"Surgeon Infiltration with Liposomal Bupivacaine (LB)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Liposomal bupivacaine","Drug: bupivacaine 0.125%","Drug: injectable saline"]},{"label":"Surgeon Infiltration","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: bupivacaine 0.5%","Drug: injectable saline"]}],"interventions":[{"name":"epidural bupivacaine 0.05%","otherNames":[]},{"name":"Liposomal bupivacaine","otherNames":[]},{"name":"bupivacaine 0.125%","otherNames":[]},{"name":"bupivacaine 0.5%","otherNames":[]},{"name":"/hydromorphone 0.05mg/ml","otherNames":[]},{"name":"injectable saline","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients undergoing cystectomy for bladder cancer\n* ASA class 1, 2, 3 or 4\n* Age 18 or older, male or female\n* Desires Regional anesthesia for postoperative pain control\n\nExclusion Criteria:\n\n* Any contraindication for thoracic epidural.\n* History of substance abuse in the past 6 months.\n* Patients on more than 30mg morphine equivalents of opioids daily.\n* Any physical, mental or medical conditions which in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.\n* Known allergy or other contraindications to the study medications (Acetaminophen, Gabapentin, Bupivacaine, Hydromorphone).\n* Postoperative intubation.\n* Any patient with history of neuropathic bowel or bladder dysfunction","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"VAS Score at 48 Hour","description":"The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"VAS Score at 72 Hour","description":"The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Endpoint Includes Total Opioid Consumption at 1 Hour Per PO Morphine Equivalent Dose","description":"Opioid consumption will be collected by a study team member post operatively at hour 1 per protocol time requirements","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":null},{"groupId":"OG001","value":"6.5","spread":null},{"groupId":"OG002","value":"5.8","spread":null},{"groupId":"OG003","value":"4.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Endpoint Includes Total Opioid Consumption at 24 Hours PO Morphine Equivalent Dose","description":"Opioid consumption will be collected by a study team member post operatively at hour 24 per protocol time requirements","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"36","spread":null},{"groupId":"OG002","value":"52","spread":null},{"groupId":"OG003","value":"30","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Endpoint Includes Total Opioid Consumption at 48 Hours PO Morphine Equivalent Dose","description":"Opioid consumption will be collected by a study team member post operatively at hour 48 per protocol time requirements","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.8","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"52","spread":null},{"groupId":"OG003","value":"44","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Endpoint Includes Total Opioid Consumption at 72 Hours PO Morphine Equivalent Dose","description":"Opioid consumption will be collected by a study team member post operatively at hour 72 per protocol time requirements","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.7","spread":null},{"groupId":"OG001","value":"32","spread":null},{"groupId":"OG002","value":"40","spread":null},{"groupId":"OG003","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Secondary Endpoint Includes Total Opioid Consumption at 96 Hours PO Morphine Equivalent Dose","description":"Opioid consumption will be collected by a study team member post operatively at hour 96 per protocol time requirements","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.1","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"23.3","spread":null},{"groupId":"OG003","value":"20","spread":null}]}]}]},{"type":"SECONDARY","title":"VAS Score at 1 Hour","description":"The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":null},{"groupId":"OG001","value":"3.1","spread":null},{"groupId":"OG002","value":"2.9","spread":null},{"groupId":"OG003","value":"2.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":null},{"groupId":"OG001","value":"3.5","spread":null},{"groupId":"OG002","value":"2.7","spread":null},{"groupId":"OG003","value":"1.9","spread":null}]}]}]},{"type":"SECONDARY","title":"VAS Score at 24","description":"The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"VAS Score at 96 Hour","description":"The VAS score will be taken with both rest and movement (knee flexion) and will be measured by a study team investigator using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Nausea at 1 Hour","description":"Nausea scores will be collected by study team member post operatively at hour 1 per protocol. Result is reported as nausea or no nausea.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"3","spread":null},{"groupId":"OG003","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Nausea at 24 Hours","description":"Nausea scores will be collected by study team member post operatively at hour 24 per protocol. Result is reported as nausea or no nausea.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"9","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Nausea at 48 Hours","description":"Nausea scores will be collected by study team member post operatively at hour 48 per protocol. Result is reported as nausea or no nausea.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"10","spread":null},{"groupId":"OG003","value":"13","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Nausea at 72 Hours","description":"Nausea scores will be collected by study team member post operatively at hour 72 per protocol. Result is reported as nausea or no nausea.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"12","spread":null},{"groupId":"OG002","value":"17","spread":null},{"groupId":"OG003","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Nausea at 96 Hours","description":"Nausea scores will be collected by study team member post operatively at hour 96 per protocol. Result is reported as nausea or no nausea.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"6","spread":null},{"groupId":"OG002","value":"12","spread":null},{"groupId":"OG003","value":"14","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Sedation at 1 Hour","description":"Sedation scores will be collected by a study team member post operatively at hour 1. Results are interpreted as patient with or without any sedation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Sedation at 24 Hours","description":"Sedation scores will be collected by a study team member post operatively at hour 24. Results are interpreted as patient with or without any sedation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Sedation at 48 Hours","description":"Sedation scores will be collected by a study team member post operatively at hour 48. Results are interpreted as patient with or without any sedation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Sedation at 72 Hours","description":"Sedation scores will be collected by a study team member post operatively at hour 72. Results are interpreted as patient with or without any sedation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Sedation at 96 Hours","description":"Sedation scores will be collected by a study team member post operatively at hour 96. Results are interpreted as patient with or without any sedation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"First Flatus-bowel Movement","description":"The first time the patients passes gas post operatively.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.3","spread":null},{"groupId":"OG001","value":"55.5","spread":null},{"groupId":"OG002","value":"69.7","spread":null},{"groupId":"OG003","value":"59.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Creatinine","description":"Lab level of Creatinine will be recorded for 4 days post operatively.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"0.98","spread":null},{"groupId":"OG002","value":"1.08","spread":null},{"groupId":"OG003","value":"0.96","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Discharge-Length of Stay","description":"Length of Stay will be collected from Cerner Electronic Medical Record. Pt. followed for length of stay, up till 4 weeks after surgery.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":null},{"groupId":"OG001","value":"6.0","spread":null},{"groupId":"OG002","value":"6.4","spread":null},{"groupId":"OG003","value":"7.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Hypotension","description":"Defined as BP decrease of more than 20% from baseline. The reported number for each arm is the cumulative number of hypotension episodes experienced in each arm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"16","spread":null},{"groupId":"OG003","value":"26","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Respiratory Depression","description":"Define by use of Narcan","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Ambulation Activity Postoperatively","description":"Number of participants who got out of bed and is ambulatory on Postoperative Day 1 and postoperative Day 2","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"35","spread":null},{"groupId":"OG002","value":"38","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["Ileus","respiratory depression"]}}}